Avapritinib Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia With KIT Mutations
Latest Information Update: 15 Jan 2025
Price :
$35 *
At a glance
- Drugs Avapritinib (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 15 Jan 2025 New trial record